BIOMAT Database Logo BIOMAT Database Logo

Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases. 1978

R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore

Intra-amniotic hyperosmolar urea (59.7 per cent) augmented by intravenous oxytocin (332 millimicron per minute), prostaglandin F2alpha (20 mg.), prostaglandin F2alpha (10 mg.), or prostaglandin F2alpha (5 mg.) was utilized for 1,913 patients requesting elective midtrimester abortion. Injection-abortion intervals ranging from 13.70 to 21.49 hours were achieved with failure rates of 0.7 to 6.7 per cent. Despite frequent pre-existing medical conditions, the complication rate compared favorably with those of other methods for terminating midtrimester pregnancy such as saline amnioinfusion or dilatation and evacuation.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D004716 Endometritis Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever. Endomyometritis
D005260 Female Females

Related Publications

R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation.
February 1984, JAMA,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Experience with midtrimester abortion.
May 1979, Obstetrics and gynecology,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Intra-amniotic prostaglandin F2alpha and urea for midtrimester abortion.
December 1976, Fertility and sterility,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Urea and 15-me-prostaglandin F2 alpha for midtrimester abortion.
April 1979, Journal of obstetrics and gynaecology of India,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Midtrimester abortion experience in a community hospital.
November 1981, Journal of the National Medical Association,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Midtrimester abortion.
January 1981, Obstetrics and gynecology annual,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Use of hypertonic urea solution as the method of choice for midtrimester abortion.
February 1974, Obstetrics and gynecology,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Induction of midtrimester abortion with intraamniotic urea, intravenous oxytocin and laminaria.
December 1975, The Journal of reproductive medicine,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Induction of midtrimester abortion with intra-amniotic urea and intravenous oxytocin.
February 1977, American journal of obstetrics and gynecology,
R T Burkman, and M F Atienza, and T M King, and J A Tonascia, and J C Pang, and A J Whitmore
Clinical experience using intraamniotic prostaglandin F2alpha for midtrimester abortion in 600 patients.
November 1975, Obstetrics and gynecology,
Copied contents to your clipboard!